August 23, 2021

How to cast a smarter net

Taking a new approach to expert identification can reshape outcomes for life science teams.
KOL selection

For many pharmaceutical and medical device teams, KOL selection can go one of two ways: defaulting to the list of KOLs they always use or outsourcing the work to a third party. Problem is, there are drawbacks to both approaches. Going back to the same people over and over again lets you talk to the experts you know best – but they might not be the best people to provide insight on every topic or therapeutic area. And hiring a third party can be time-consuming and expensive.

Related Posts:

what is real world data

Guide to real-world data vs real-world evidence

The two concepts are similar but distinct. Explore the differences and learn how they’re used.
insights management technology explained

Insights management technology is a game-changer for life science teams

A Within3 expert shares how insights management technology supports the drug and device development process and creates opportunities for life science teams.
what is stakeholder engagement

What is stakeholder engagement?

Choosing the right stakeholders is just the beginning – more effective engagement environments yield better insights and support faster decision-making.